A 73-Year-Old Man With Relapsed Chronic Lymphocytic Leukemia

Danielle M. Brander, MD, remarks on the appropriateness for targeted therapy as a treatment option for a 73-year-old man with relapsed chronic lymphocytic leukemia.

EP. 1: Impressions of a 73-Year-Old Man With Relapsed CLL

June 8th 2020

EP. 2: Frontline Targeted Therapy for CLL

June 8th 2020

EP. 3: BTK Monotherapy as Frontline Treatment of CLL

June 8th 2020

EP. 4: MRD Assessment and Treatment Selection in CLL

June 8th 2020

EP. 5: Treatment Options for Relapsed CLL

June 8th 2020

EP. 6: PI3K/Anti-CD20 Therapy for Relapsed/Refractory CLL

June 8th 2020

EP. 7: Addressing Treatment Challenges in CLL

June 8th 2020